Cholinergic stimulation may mitigate arrhythmic risk during treatment of COVID-19

: International Physical Medicine & Rehabilitation Journal
: Renata RT Castro,^1,2,3Marco Antonio Orsini Neves,¹João Giffoni da Silveira Neto,^1,3Roberta RT Castro¹

Keywords

pharmacologic options, old antimalarial drugs, chloroquine and hydroxychloroquine, people argument, rapidly activating, ventricular tachyarrhythmia, mitigation focus, arrhythmias, malignant arrhythmia, exercise tolerance

© 2014-2024 MedCrave Group, All rights reserved. Our Website using on the Understanding that Full Credit will be given to the Source.
MedCrave Group is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at www.medcrave.com
Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version | Opera | Privacy Policy

Testimonials

Cholinergic stimulation may mitigate arrhythmic risk during treatment of COVID-19

Keywords

Quick Links

Related Journals